Impact of CYP2D6 and CYP3A4 genetic polymorphism on combined cholinesterase inhibitors and memantine treatment in mild to moderate Alzheimer's disease.
Dementia and geriatric cognitive disorders 2014 37 (1-2): 58-70.
Sonali Nirmal, Tripathi Manjari, Sagar Rajesh, Velpandian Thirumurthy, Subbiah Vivekanandh
- Page last reviewed:Mar 1, 2018
- Page last updated:Jun 13, 2019
- Content source: